Skip to main content

Invitrogen Divests German BioReliance Manufacturing Unit to Investor Group; Business Not Aligned With Invitrogen s Goals

This update serves to clarify that Invitrogen has divested the Heidelberg, Germany-based unit of its BioReliance business. The BioReliance business itself, which Invitrogen will retain, is based in Rockville, Md. The original story was based on a press release that did not describe the relationship between the Heidelberg and Rockville businesses.

NEW YORK, April 27 (GenomeWeb News) - Invitrogen has sold its BioReliance Manufacturing business to a consortium of investors led by BioReliance's managing director, the company said today.


After the management buy-out, which was led by Thomas Pultar, the company will be called BIOMEVA.


BioReliance Manufacturing is based in Heidelberg, Germany. It is a "small part" of the overall BioReliance business, based in Rockville, Md., which Invitrogen will retain, according to a company spokesperson.


Terms of the divestiture were not disclosed. Invitrogen acquired Rockville-based BioReliance in December 2003 for $500 million.


"Bacterial contract manufacturing was not aligned with our strategic direction," Bernd Brust, vice president and general manager for Invitrogen Europe, said in a statement.


BioReliance Manufacturing offers fermentation and purification services using recombinant and natural microorganisms. The new company will continue this model, it said.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.